Melanoma

News

FDA Approves Atezolizumab Combo for BRAF V600+ Melanoma

08/03/2020

The FDA has approved atezolizumab plus cobimetinib and vemurafenib for the treatment of patients with BRAF V600 mutation-positive unresectable or metastatic melanoma.

The FDA has approved...

08/03/2020

Oncology

News

Advances in RT Lead to Improved Outcomes in Patients With Melanoma Brain Metastases

07/30/2020

The evolution of RT techniques and therapies for melanoma brain metastases have improved outcomes among patients since 2007, according to a population-based study.

The evolution of RT techniques...

07/30/2020

Oncology

Commentary

Measuring Immune Checkpoint Inhibition Efficacy via Treatment-Free Survival in Advanced Melanoma

04/20/2020

Experts are developing a novel clinical trial outcome measure to characterize the antitumor activity of ICI protocol therapy in advanced melanoma.

Experts are developing a novel...

04/20/2020

Oncology

News

Immune Checkpoint Inhibitor Type, Dose Influence Risk for AEs in Melanoma

04/09/2020

A review of randomized trials in patients with advanced melanoma showed that the risk for immune-related AEs varies based on immune checkpoint inhibitor type and dose.

A review of randomized trials in...

04/09/2020

Oncology

News

Nomogram Could Help Select Patients With Melanoma to Undergo Biopsies

04/01/2020

Researchers propose using an externally validated nomogram to better select patients with T1 melanoma to undergo sentinel node biopsy.

Researchers propose using an...

04/01/2020

Oncology

News

Study Findings Stress Importance of Primary Tumor Mitotic Rate in Melanoma

02/10/2020

Study findings highlight the importance of the primary tumor mitotic rate, and provide a framework for evidence-based surveillance of CNS metastasis in stage III melanoma.

Study findings highlight the...

02/10/2020

Oncology

Interview

Monitoring Ipilimumab Response in Patients with Metastatic Melanoma

05/07/2019

Wolfgang Weber, MD, discusses the link between tumor response on 18F-FDG PET/CT and prognosis in patients treated with ipilimumab.

Wolfgang Weber, MD, discusses...

05/07/2019

Oncology